Essais liés13clinical trials
VilleJacksonvillelocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT04259255

Ouvrir le site du centre

Essais cliniques associés

13
MoléculeIndication / populationPhaseNCTTitreStatut
Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders Sclérose latérale amyotrophique À vérifier NCT05474235 Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders RECRUITING
Ranolazine Sclérose latérale amyotrophique Phase 2 NCT06527222 A Study of Ranolazine in ALS RECRUITING
Edaravone (Radicava®/Radicava ORS®) Sclérose latérale amyotrophique À vérifier NCT04259255 Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) COMPLETED
Neurostimulator Migraine Non applicable NCT06167655 A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM ACTIVE_NOT_RECRUITING
AAV9-hSyn1-miGRIK2 Épilepsie Phase 1/2 NCT06063850 GenTLE — AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy RECRUITING
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) Sclérose latérale amyotrophique À vérifier NCT04363684 ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) RECRUITING
CABA-201 Myasthénie Phase 1/2 NCT06359041 RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis RECRUITING
Hybrid argon plasma ablation (HAPC) Cancer Non applicable NCT03621319 BURN — Eradicating Barrett's Esophagus Using Radiofrequency Ablation or a Novel Hybrid Argon Plasma Coagulation Technique TERMINATED
XEN1101 Épilepsie Phase 3 NCT05667142 X-ACKT — A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures RECRUITING
XEN1101 Épilepsie Phase 3 NCT05718817 X-TOLE4 — An Open-label Study of XEN1101 in Epilepsy ENROLLING_BY_INVITATION
Celecoxib Sclérose latérale amyotrophique Phase 2 NCT00355576 Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis COMPLETED
Atogepant 60 mg Migraine Phase 4 NCT06972056 Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study RECRUITING
Zilucoplan Sclérose latérale amyotrophique Phase 2/3 NCT04297683 HEALEY ALS Platform Trial - Master Protocol ACTIVE_NOT_RECRUITING